Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
AstraZeneca to offer up to 80% off US drug prices
AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.
Read more
AstraZeneca to offer up to 80% off US drug prices
AstraZeneca joins Trump’s drug pricing plan, pledging $50bn US investment and discounts of up to 80% to cut prescription medicine costs.
NIHR funds £1.5m in innovative digital health projects
The UK’s NIHR has invested £1.5M in digital health to cut paediatric mental health waiting times.
Could the brain be a target for autoimmune disease?
A new biotech company in New York, Nilo Therapeutics, believes the brain could hold the key to treating immune diseases.
ABPI calls for NICE cost-effectiveness threshold review
ABPI calls for NICE to raise its cost effectiveness threshold for new medicine, which hasn’t raised in 20 years and is not linked to inflation.
Potential breakthrough in brain-computer interface research
New research from Precision Neuroscience shows its brain-computer interface can record high-resolution signals without invasive surgery.
FTSE 100 hits new high as UK pharma stocks surge
UK pharma and healthcare stocks drive FTSE 100 to a record high, led by AstraZeneca, as trade policy shifts boost investor confidence.
Month in pharma news, explained – September 2025
Read this month’s pharma news roundup, featuring AI in healthcare risks, GLP-1 drug trials beyond obesity and Trump’s US tariffs.
NHS Online digital hospital to launch by 2027
England’s NHS is launching NHS Online, a fully digital hospital, to speed up specialist appointments, cut wait times and improve care access.
Loading posts...
1
2
3
…
36
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View